E
ExcepGen
Biotech & Life Sciences · San Francisco, United States · Founded 2017
Biotechnology company solving fundamental underlying problems in drug discovery to create a new generation of therapeutics MoreLess
ExcepGen operates in the biotechnology sector, focusing on the development of advanced nucleic acid therapeutics. The company serves pharmaceutical firms and research institutions by providing a unique platform that modifies how cells respond to DNA and mRNA, aiming to create more effective drugs and vaccines. ExcepGen's business model revolves around licensing its technology and forming strategic partnerships with industry leaders. Revenue is generated through licensing fees, research collaborations, and milestone payments. The company is driven by a team of visionary scientists dedicated to improving human health by exploring foundational principles of biology. ExcepGen fosters a culture of curiosity and interdisciplinary collaboration, seeking individuals who can bridge the gaps between biochemistry, cell biology, and therapeutic design. Keywords: nucleic acid therapeutics, DNA, mRNA, cellular response, advanced drugs, vaccines, biotechnology, pharmaceutical partnerships, research collaborations, interdisciplinary science.
Talent graph
ExcepGen's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where ExcepGen has talent and traffic
team presence
Market sentiment
What the market is saying about ExcepGen
An AI-synthesized read of the highest-engagement posts about ExcepGen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ExcepGen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.